Postoperative Pain After Caesarian Section

Pain, Postoperative Clinical Trial

Official title: Impact of Guideline Recommendations for Post-caesarean Analgesia on Pain, Nausea and Pruritus

Status Completed

Clinical Trial Summary

To examine if perioperative pain/nausea/pruritus is altered when current standard analgesia for caesarian section (CS) is replaced with new guideline recommended analgesia.

Clinical Trial Description

Control group (current analgesia, elective CS) is compared to current analgesia for emergency CS, and guideline recommended analgesia. Current analgesia for CS: Spinal hyperbaric bupivacaine 5 mg/ml, 9-11 mg. Spinal fentanyl 10-15 ug. Postoperative: Paracetamol 1g x 4, ibuprofen 400 mg x 4 po, oxycodone 10 mg (<70 kg) or 20 mg (>70 kg) x 2 po, additional oxycodone 2,5 mg iv/5 mg po when needed. Guideline recommended analgesia for CS: Spinal hyperbaric bupivacaine 5 mg/ml, 9-11 mg. Spinal fentanyl 12,5 ug. Spinal morphine 0,05 mg. After delivery of baby: Dexamethasone 8 mg iv, paracetamol 1g iv, parecoxib 40 mg iv. Postoperative: Paracetamol 1g x 4, ibuprofen 600 mg x 4 po, oxycodone 2,5 mg iv/5 mg po when needed. ;

Related Conditions & MeSH terms

• Consumption
• Nausea
• Pain, Postoperative
• Pruritus
• Vomiting

• NCT number: NCT05659823
• Study type: Interventional
• Source: Helse Stavanger HF
• Status: Completed
• Phase: Phase 4
• Start date: November 2, 2020
• Completion date: November 5, 2021